Product Name | MF | CAS | Details |
---|
14:0-14:0-d27 Pc | 185906-03-0 | Details |
1-Piperidin-4-yl-1,3-dihydro-2H-indol-2-one | C13H16N2O | 16223-25-9 | Details |
IL3R antibody (Tyr593) | Details |
H-RLL^GTEFQV-OH | Details |
Bromofluoroacetic Acid | C2H2BrFO2 | 359-25-1 | Details |
MSC 2032964A | C16H13F3N6O | 1124381-43-6 | Details |
1-(2-Aminocyclopentyl)piperidin-4-ol dihydrochloride | C10H21ClN2O | 2089257-92-9 | Details |
4-Ethoxythieno[2,3-b]pyridine-2-carboxylic acid | C10H9NO3S | 2225136-30-9 | Details |
PKAR2 beta antibody (Ser113) | Details |
Hexatriacontane | C36H74 | 630-06-8 | Details |
3-Amino-N-cyclopentylpropanamide | C8H16N2O | 938339-02-7 | Details |
1-(3-Bromo-4-methoxyphenyl)-N-methylmethanamine hydrochloride | C9H12BrNO.ClH | 855272-08-1 | Details |
3,4-Di-O-acetyl-1,6-anhydro-2-deoxy-2-fluoro-b-D-glucopyranose | C10H13FO6 | 23236-00-2 | Details |
(3beta)-Cholest-5-en-3-yl acetate | C29H48O2 | 604-35-3 | Details |
2-[2-(3-Hydroxybenzamido)-1,3-thiazol-4-yl]acetic acid | C12H10N2O4S | 926207-29-6 | Details |
6-O-Benzyl-1-(-)-carboxymenthyl-2,3:4,5-di-O-cyclohexylidene-L-myo-inositol | C36H52O8 | 190513-80-5 | Details |
6-Hydroxy-2-oxo-2H-chromene-4-carboxylic acid | C10H6O5 | 1522234-59-8 | Details |
CCL5 antibody (HRP) | Details |
N,N'-Di-tert-butylethylenediamine | C10H24N2 | 4062-60-6 | Details |
2,4-Dimethyl-6-(methylsulfanyl)pyrimidine-5-carboxylic acid | C8H10N2O2S | 929975-29-1 | Details |
1-[(2,4-Dichlorophenyl)methyl]-1H-pyrazol-5-amine | C10H9Cl2N3 | 929028-88-6 | Details |
HLA-DOB protein (His tag) | Details |
Toceranib | C22H25FN4O2 | 356068-94-5 | Details |
Glyoxal-hydroimidazolone isomer | C8H14N4O3 | 207856-23-3 | Details |
4-Bromopicolinic hydrazide | C6H6BrN3O | 62150-48-5 | Details |
Cuban-1-amine hydrochloride | C8H10ClN | 124783-65-9 | Details |
2-Methoxy-3,5-dimethylbenzene-1-sulfonamide | C9H13NO3S | 1341641-01-7 | Details |
4-Methoxy-2,2-dimethylbutanoic acid | C7H14O3 | 1338986-76-7 | Details |
Diclobutrazol | C15H19Cl2N3O | 75736-33-3 | Details |
p-Coumaric acid 4-O-sulfate disodium | C9H6Na2O6S | 308338-96-7 | Details |
N-Hydroxy-2-(naphthalen-1-yl)acetamide | C12H11NO2 | 10335-80-5 | Details |
SP-6-27 | C24H24N4O | 1384170-58-4 | Details |
AZD 9272 | C14H6F2N4O | 327056-26-8 | Details |
6-Methoxy-2-oxo-1,2-dihydroquinoline-3-carbonitrile | C11H8N2O2 | 123990-79-4 | Details |
(R)-(3-Fluorophenyl)oxirane | C8H7FO | 403501-35-9 | Details |
2-Chloro-3-cyanoquinoline | C10H5ClN2 | 95104-21-5 | Details |
4-Ethoxycinnamic acid | C11H12O3 | 2373-79-7 | Details |
Spiro almotriptan | C17H25N3O3S | 1309457-18-8 | Details |
5,3',4'-Trimethoxyflavone | C18H16O5 | 136198-18-0 | Details |
GHRHR antibody | Details |
5-(Bromomethyl)-3-(2,4-dichlorophenyl)-1,2-oxazole | C10H6BrCl2NO | 5301-00-8 | Details |
rec beta-Defensin 1 (human) | Details |
2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethyl acetatequetiapine acetate | C23H27N3O3S | 844639-07-2 | Details |
5-(((4-methoxy-2-nitrophenyl)amino)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione | C14H14N2O7 | 25165-69-9 | Details |
Imidazo[2,1-b][1,3]thiazole-5-sulfonyl chloride | C5H3ClN2O2S2 | 1367929-96-1 | Details |
3-Bromo-4-(difluoromethyl)thiophene | C5H3BrF2S | 1784977-09-8 | Details |
4-Chloro-2-{[(4-chlorophenyl)sulfanyl]methyl}-5,6-dimethylthieno[2,3-d]pyrimidine | C15H12Cl2N2S2 | 793727-83-0 | Details |
1-(Piperidin-4-ylmethyl)indoline | C14H20N2 | 883549-96-0 | Details |
3-Chloro-1-ethyl-1,2-dihydropyrazin-2-one | C6H7ClN2O | 58909-71-0 | Details |
Rat IGF1 ELISA Kit | Details |
5-(4-Fluorophenyl)-5-methylimidazolidine-2,4-dione | C10H9FN2O2 | 428-22-8 | Details |
Z-Val-Lys-Lys-Arg-4MbNA hydrochloride salt | C42H62N10O7 | 71003-01-5 | Details |
3-Oxo-4-aza-5-alpha-androstane-17-beta-carboxylic acid | C19H29NO3 | 103335-55-3 | Details |
[1,2,3]Triazolo[1,5-a]pyridine-7-carboxylic acid | C7H5N3O2 | 1555335-57-3 | Details |
2-(4-oxo(3-hydroquinazolin-2-ylthio))-N-(4-(trifluoromethoxy)phenyl)ethanamide | C17H12F3N3O3S | 1022318-36-0 | Details |
Dicyclohexylidene pinitol | C13H22O6 | 57819-56-4 | Details |
DDHD2 Blocking Peptide | Details |
2-[4-Chloro-5-methyl-2-(propan-2-yl)phenoxy]acetohydrazide | C12H17ClN2O2 | 331761-39-8 | Details |
3,6-Dinitrobenzene-1,2-dicarboxylic acid | C8H4N2O8 | 2300-16-5 | Details |
7-Methylquinoline-8-sulfonamide | C10H10N2O2S | 1461714-87-3 | Details |
7-(Propan-2-yl)-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-5-carboxylic acid | C11H10F3N3O2 | 1784657-90-4 | Details |
1-(2,4,5-Trifluorophenyl)-1H-pyrazol-3-amine | C9H6F3N3 | 1343463-44-4 | Details |
3-(Thiophen-2-ylmethylidene)-1H,2H,3H-cyclopenta[b]quinoline-9-carboxylic acid | C18H13NO2S | 379728-15-1 | Details |
1-(4-Hydroxyphenyl)azetidin-2-one | C9H9NO2 | 1309606-48-1 | Details |
(4-Phenyl-4H-1,2,4-triazol-3-yl)methanol | C9H9N3O | 138624-62-1 | Details |
N-Phenylsulfamoyl chloride | C6H6ClNO2S | 60260-49-3 | Details |
((4-bromo-2-methyl-5-oxo-1-phenyl(3-pyrazolin-3-yl))methyl)thiocarboxamidine, hydrobromide | C12H14Br2N4OS | 14039-66-8 | Details |
3-(Methoxymethyl)oxolan-3-amine hydrochloride | C6H14ClNO2 | 1909337-70-7 | Details |
Spermidine synthase antibody | Details |
IKK alpha antibody (Thr23) | Details |
H-IPYV-OH | Details |
6-(2-Amino-5-methyl-1,3-thiazol-4-yl)-1,2,3,4-tetrahydroquinolin-2-one | C13H13N3OS | 105316-84-5 | Details |
(1S)-1-[5-Chloro-2-(difluoromethoxy)phenyl]ethan-1-amine hydrochloride | C9H11Cl2F2NO | 1384435-40-8 | Details |
H-TSLNLQKDEPNGRASDTAGQ-OH | Details |
tert-Butyl N-(3-bromo-2-methylpropyl)carbamate | C9H18BrNO2 | 1510268-47-9 | Details |
2-(3-Carbamoyl-1H-indol-1-yl)acetic acid | C11H10N2O3 | 1016689-54-5 | Details |
tert-Butyl 4-(2-sulfamoylethyl)piperazine-1-carboxylate | C11H23N3O4S | 1354952-77-4 | Details |
2-Methyl-2-phenylpropanehydrazide | C10H14N2O | 5809-15-4 | Details |
SERPINI1 Blocking Peptide | Details |
LCBiot-PKPLKKLRFD-NH2 | Details |
Aldol??515 beta-D-xylopyranoside, Biosynth Patent: EP 2427431 and US 8940909 | C28H28N2O6 | 2484873-01-8 | Details |
3-(4H-1,2,4-Triazol-4-yl)propan-1-amine dihydrochloride | C5H11ClN4 | 1609403-30-6 | Details |
4-(Dimethylamino)-4-phenylbutanoic acid hydrochloride | C12H18ClNO2 | 1820705-88-1 | Details |
4-(3-Ethylphenyl)-5-(morpholin-4-yl)-4H-1,2,4-triazole-3-thiol | C14H18N4OS | 854137-58-9 | Details |
1-Penten-4-yn-3-ol | C5H6O | 14304-27-9 | Details |
7-Butyl-8-(3,5-diethyl-1H-pyrazol-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione | C17H24N6O2 | 1014032-14-4 | Details |
6-Chloro-2,3-dihydro-1-benzofuran-5-amine | C8H8ClNO | 1173434-87-1 | Details |
SLC25A34 Blocking Peptide | Details |
MRAS protein (His tag) | Details |
Goat anti-human IgM, Ig Fraction | Details |
4-{[(3-Methyl-1,2-oxazol-5-yl)methyl]sulfanyl}pyrimidine-5-carboxylic acid | C10H9N3O3S | 1864073-32-4 | Details |
2,3,4,5-Tetrahydro-1,4-benzoxazepin-7-ol hydrochloride | C9H12ClNO2 | 1989672-73-2 | Details |
EEF1G protein (His tag) | Details |
Methyl 3-(methoxymethyl)pyrrolidine-3-carboxylate hydrochloride | C8H15NO3.ClH | 2378502-26-0 | Details |
N-(2-Aminoethyl)-2-phenylacetamide hydrochloride | C10H15ClN2O | 36850-99-4 | Details |
SARS-CoV-2 ORF1ab (3183-3191) | Details |
3-[5-(1-Methyl-1H-pyrazol-4-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]propan-1-amine | C11H14F3N5 | 1006319-18-1 | Details |
C21ORF18 Blocking Peptide | Details |
3,6,6-Trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indole-2-carboxylic acid | C12H15NO3 | 129689-88-9 | Details |
Synaptojanin 1 Blocking Peptide | Details |
Product Total: Product Page: | ||||
346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 |